Al-Marsad newspaper: The CEO of the Food and Drug Authority, Hisham Al-Jadhai, said that the fourth dose of the Corona vaccine was estimated for specific groups, and the Ministry of Health is following up on the health situation in the community, and the process of following up on the side effects of the doses continues.
He added in the program “In Public” on the Saudi channel: “The company is conducting a study for a period of one and a half or two years, and it was forced to submit the study following 6 months or a year, and following the completion of the study, the data is sent.”
He continued, “The data was sent, and there are no changes or risks, and this is very reassuring that the decisions that were taken in the vaccines were correct.”